{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-118934","form_type":"8-K","ticker":"CAPR","cik":"0001133869","company_name":"CAPRICOR THERAPEUTICS, INC.","filed_at":"2025-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.868820+00:00","generated_at":"2026-05-16T14:12:11.532441+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Capricor Therapeutics prices $150M public offering of 6M shares at $25/sh","bullets":["Offering 6,000,000 shares at $25.00 per share; expected gross proceeds ~$150M.","Underwriters granted 30-day option to purchase up to 900,000 additional shares.","Net proceeds for product candidate development, manufacturing, working capital, and corporate purposes.","Joint book-running managers: Piper Sandler & Co. and Oppenheimer & Co.; co-manager: H.C. Wainwright & Co.","Offering expected to close on or about December 8, 2025, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-118934","json":"https://secwatch.observer/filing/0001104659-25-118934.json","markdown":"https://secwatch.observer/filing/0001104659-25-118934.md","text":"https://secwatch.observer/filing/0001104659-25-118934.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133869/000110465925118934/0001104659-25-118934-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133869/000110465925118934/capr-20251205x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:12:11.532441+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}